FeesSafety
Pluang+

Artiva halts lead drug program after fatal trial events, stock plunges 31%.

Market News
18 Nov 2026, 01:13 WIB
GlobeNewsWire
View Source
Bearish
Artiva halts lead drug program after fatal trial events, stock plunges 31%.

Artiva Biotherapeutics announced it is stopping development of its lead drug AlloNK® after clinical data showed poor durability and two patient deaths. This led to a 94% workforce cut and plans to explore strategic options like a merger or liquidation. The stock dropped 30.68% on the news. Investors are now involved in a securities fraud investigation by Pomerantz LLP regarding the company’s disclosures and business practices.

Artiva Biotherapeutics faces a securities fraud investigation following its drug development halt and workforce cuts. For readers following the health sector, here is Pluang's market snapshot as of Nov 18, 2026 06:31 WIB: out of 150 priced US health stocks, 36 rose and 113 fell. Notable movers include SYRE at USD 93.40 with a 6.01% drop and CTXR at USD 0.51 down 5.73%.

More News

Lunar Outpost opens new HQ in Colorado to boost lunar vehicle production and support NASA Moon Base.

Lunar Outpost opens new HQ in Colorado to boost lunar vehicle production and support NASA Moon Base.

Lunar Outpost has inaugurated a new 62,500-square-foot headquarters in Colorado to expand its capacity for building, testing, and operating lunar vehicles and infrastructure. This facility consolidates vehicle development, assembly, and mission contr...

Market News
Bullish
33 minutes ago
Global tractor market to hit $131.3B by 2032, led by Asia-Pacific with rising demand for mid-range and electric models.

Global tractor market to hit $131.3B by 2032, led by Asia-Pacific with rising demand for mid-range and electric models.

The global tractor market is projected to grow from USD 100.6 billion in 2027 to USD 131.3 billion by 2032, with a CAGR of 5.47%. Asia-Pacific dominates with a 55.66% market share, driven by strong manufacturing and demand in India. Mid-range tractor...

Bullish
1 hour ago
Nexus Advanced Technologies faces Nasdaq delisting over low share price, plans to appeal and propose share consolidation.

Nexus Advanced Technologies faces Nasdaq delisting over low share price, plans to appeal and propose share consolidation.

Nexus Advanced Technologies received a Nasdaq Staff Delisting Determination due to its share price staying below $1.00 for 30 consecutive business days. Because of a recent reverse stock split, the company is ineligible for the usual compliance perio...

Market News
Bearish
2 hours ago
Billor partners with Mack Trucks and Pathway to add 50 new trucks, boosting its transportation platform growth

Billor partners with Mack Trucks and Pathway to add 50 new trucks, boosting its transportation platform growth

Billor Holding LLC has formed a strategic partnership with Mack Trucks and Pathway to enhance its transportation platform by initially adding 10 new Mack Pioneer sleeper tractors, with plans to introduce a total of 50 vehicles soon. Mack Trucks will ...

Company Fundamentals
Bullish
2 hours ago
Construction of Pennsylvania's first Tempo by Hilton hotel hits major milestone with topping out ceremony.

Construction of Pennsylvania's first Tempo by Hilton hotel hits major milestone with topping out ceremony.

High Hotels Ltd. celebrated the topping out of Tempo by Hilton Bethlehem, marking the completion of the hotel's structural framework. This milestone advances the development of Pennsylvania's first Tempo by Hilton, an eight-story, 140-room lifestyle ...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App